BNP Paribas Exane upgraded Hypoport (HYPOF) to Outperform from Neutral with a EUR 210 price target The firm sees strong earnings growth ahead of the company.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential